Animal study finds low protein diet slows liver tumor growth and enhances survival — Evidence Review
Published in Science Advances, by researchers from Rutgers University
Researched by
— the AI search engine for science
Table of Contents
People with impaired liver function may reduce their risk of liver cancer or slow its progression by lowering dietary protein intake, according to new research. Most related studies generally support the idea that protein restriction can reduce tumor growth and improve survival, especially in animal models, though some findings in humans are mixed; the full study is summarized by Rutgers University.
- Several animal studies demonstrate that low-protein diets decrease tumor growth, extend lifespan, and reduce cancer incidence, particularly when liver function is compromised or when protein intake is reduced substantially 1 7 9 12.
- Observational studies in humans suggest more nuanced outcomes: while some link lower protein intake to reduced cancer risk and mortality in middle age, others indicate that higher total protein intake before diagnosis may be associated with improved survival in hepatocellular carcinoma (HCC) patients, highlighting the need for individualized dietary recommendations 4 6.
- The mechanistic findings of ammonia buildup promoting tumor growth in the new study align with earlier research showing that high-protein or high-animal fat/protein diets can elevate liver stress and cancer risk, while plant-based proteins and diets may confer protective effects 2 5 9.
Study Overview and Key Findings
Liver cancer remains one of the most fatal primary cancers in the United States, with limited treatment options and a high mortality rate. As the prevalence of liver disease rises—due to factors such as fatty liver, viral hepatitis, and alcohol use—understanding how dietary interventions might alter cancer risk or progression is particularly important. This study addresses a longstanding clinical question: does impaired ammonia metabolism in the liver merely result from cancer, or can it actively drive tumor growth? By elucidating this mechanism and testing dietary interventions in a preclinical model, the study provides new insights into how a simple dietary change could impact disease trajectory in at-risk populations.
| Property | Value |
|---|---|
| Study Year | 2023 |
| Organization | Rutgers University |
| Journal Name | Science Advances |
| Authors | Wei-Xing Zong |
| Population | Mice with liver tumors |
| Methods | Animal Study |
| Outcome | Liver tumor growth, survival rates |
| Results | Mice on a low protein diet had slower tumor growth and longer survival. |
Literature Review: Related Studies
To evaluate the broader context of this research, we searched the Consensus database, which indexes over 200 million scientific papers. Our search used the following queries:
- low protein diet liver cancer
- tumor growth protein intake effects
- survival rates protein restriction mice
Related Studies by Topic
| Topic | Key Findings |
|---|---|
| How does dietary protein intake affect tumor growth and cancer risk? | - Low-protein diets in animal models consistently slow tumor growth and may reduce cancer incidence 1 7 9. - In contrast, high-protein diets can induce liver stress and apoptosis in animal studies 3. |
| What is the role of protein source (plant vs. animal) and diet composition? | - Plant-based low-carbohydrate diets are associated with lower HCC risk, while animal-based low-carb/high-protein diets may increase risk 2 5. - Plant protein may reduce tumor growth more than animal protein 9. |
| Can protein or calorie restriction improve survival and longevity? | - Lifelong protein restriction can extend lifespan and reduce frailty in mice, with effects influenced by sex and metabolic signaling pathways 12 14. - Caloric and protein restriction both prolong survival in some mouse strains 10 11. |
| How does protein intake relate to cancer survival and prognosis in humans? | - Higher prediagnostic total protein intake may be linked to reduced mortality in HCC patients 4. - Low protein intake during middle age may reduce cancer risk, but higher intake could benefit older adults 6. |
How does dietary protein intake affect tumor growth and cancer risk?
Many animal studies demonstrate that reducing dietary protein slows tumor growth, decreases cancer incidence, and may extend lifespan, particularly in models with compromised liver function. The new Rutgers study aligns with this evidence, showing that low protein intake reduces ammonia buildup and limits resources for tumor cells. However, some studies highlight potential adverse effects of very high protein diets, such as increased liver stress and apoptosis.
- Animal models fed low-protein diets have slower tumor growth and fewer cancer-related deaths 1 7 9.
- High-protein, high-fat, low-carbohydrate diets can cause liver cell apoptosis and elevated liver enzymes, indicating hepatic stress 3.
- The mechanism identified in the new study—ammonia fueling cancer cell metabolism—provides a direct link between protein intake, liver function, and tumor progression 1 7.
- Not all tumor types respond equally to protein restriction, but spontaneous liver tumors in mice appear particularly sensitive 7.
What is the role of protein source (plant vs. animal) and diet composition?
The composition and source of dietary protein, as well as macronutrient balance, appear important in modulating cancer risk. Human observational studies suggest plant-based protein and fat may reduce HCC risk, while animal-based low-carb, high-protein diets could increase it. Experimental studies in animal models further support the idea that plant-derived proteins are less likely to support tumor growth.
- Plant-based low-carbohydrate diets are linked to a lower risk of HCC, while high animal fat/protein intake increases risk 2 5.
- Substituting plant protein for carbohydrates or refined grains is associated with reduced HCC incidence 2.
- In animal models, diets with plant protein inhibit tumor growth more than equivalent animal protein diets 9.
- The new study did not distinguish protein source, but its findings are consistent with literature emphasizing the importance of protein quality and origin 2 5 9.
Can protein or calorie restriction improve survival and longevity?
Caloric and protein restriction have well-documented effects on longevity and cancer resistance in animal models. Lifelong low-protein or branched-chain amino acid restriction extends lifespan and delays age-related decline in mice, often through metabolic pathways involving insulin signaling and stress response hormones.
- Lifelong protein or branched-chain amino acid restriction can increase lifespan and reduce frailty in mice, with sex-dependent effects 12 14.
- Caloric restriction and protein restriction both prolong survival in various mouse strains, sometimes with different efficacy depending on strain and disease susceptibility 10 11.
- Dietary restriction can also enhance immune surveillance and reduce age-related disease, including spontaneous cancer 10 12.
- The new study's finding that low-protein diets prolong survival in mice with liver tumors is consistent with these broader effects 10 12 14.
How does protein intake relate to cancer survival and prognosis in humans?
Human studies show a more complex relationship between protein intake and cancer outcomes. Some suggest that higher total protein intake before diagnosis is linked to reduced mortality in HCC patients, while other research indicates the benefits of lower protein intake in middle age for reducing cancer risk, with a possible reversal in older adults.
- Higher prediagnostic total protein intake was associated with reduced all-cause and HCC-specific mortality in a prospective cohort of HCC survivors 4.
- Low protein intake during middle age (50–65 years) is linked to lower cancer mortality, but higher intake may be beneficial after age 65 6.
- The timing and context of protein restriction (pre-diagnosis vs. during treatment) may influence its effects on survival and prognosis 4 6.
- These findings highlight the need for individualized dietary recommendations, especially for cancer patients with compromised liver function 4 6.
Future Research Questions
Further research is critical to clarify the optimal role of dietary protein in liver disease and cancer prevention, as well as to resolve inconsistencies between animal and human findings. Questions remain about the influence of protein source, timing, patient age, and underlying liver condition on cancer risk and survival.
| Research Question | Relevance |
|---|---|
| Does reducing dietary protein intake lower liver cancer risk in humans with chronic liver disease? | Human trials are needed to validate whether the protective effect of low-protein diets seen in mice translates to people with liver disease, as most current evidence is preclinical or observational 1 4 9. |
| How does the source of dietary protein (plant vs animal) affect liver cancer risk and progression? | Studies suggest plant-based proteins may be less likely to promote tumor growth than animal proteins, but more research is needed to confirm this in liver cancer specifically 2 5 9. |
| What is the optimal protein intake for cancer patients with impaired liver function? | Balancing the need to reduce ammonia buildup against the risk of malnutrition and muscle loss is a clinical challenge; more research can guide individualized dietary recommendations for patients 4 6. |
| Does timing of protein restriction (pre-diagnosis vs during treatment) impact cancer outcomes? | Some evidence suggests prediagnostic protein intake may influence survival, while restriction during treatment could have different effects; understanding timing could improve guidelines 4 6. |
| What are the mechanisms by which ammonia accumulation promotes tumor growth in the liver? | The new study identifies ammonia's role in fueling tumor metabolism, but further mechanistic studies could reveal additional targets for intervention 1. |
This comprehensive review highlights the nuanced relationship between dietary protein, liver function, and cancer risk. While animal studies strongly support the benefits of protein restriction in slowing tumor growth and extending lifespan, translating these findings to clinical guidelines will require targeted human research and careful consideration of individual patient needs.